NIH-funded research R21 grant

Improving brain imaging techniques to study schizophrenia

Official title: Robust and highly selective proton MRSI on a clinical 3 T system using a second order gradient insert, for application in schizophrenia

Funded at Yale University · NIH-10741355 · Data updated 2026-11-12

This study is working on improving brain imaging techniques to get a clearer picture of glutamate, a key chemical, in people with schizophrenia, which could help doctors better understand and treat the condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 21, 2023
Project endSeptember 20, 2025
Funding year2023
Award (this year)$460,625
NIH project number1R21EB033911-01A1
Project IDNIH-10741355 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with schizophrenia who are interested in understanding their condition better.

Less likely to help

Patients without a diagnosis of schizophrenia or those with other unrelated neurological conditions may not benefit from this research.

What this research studies

This research focuses on enhancing Magnetic Resonance Spectroscopy and Spectroscopic Imaging (MRS/MRSI) techniques to better understand the role of glutamate in schizophrenia. By developing methods to reduce interference from lipid signals in the brain, the study aims to provide clearer images and more accurate measurements of glutamate and glutamine levels. This could lead to a better understanding of the brain's chemistry in individuals with schizophrenia, potentially improving diagnosis and treatment options. The research will be conducted using a clinical 3 Tesla MRI system, which is commonly available in medical settings.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for patients with schizophrenia.

How similar studies have gone: Previous studies using MRS/MRSI techniques have shown promise in understanding brain chemistry, but this specific approach aims to overcome significant limitations faced in earlier research.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: De Graaf, Robin a — Yale University
  • Study coordinator: De Graaf, Robin a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.